Recently, the epidemic spread from Nanjing and Zhangjiajie to many parts of the country has attracted much attention. Behind this is the continuous evolution and mutation of the novel coronavirus. Delta, a new variant of the novel coronavirus (formerly known as B.1.617.2), has been the main strain of the global epidemic since it was first discovered in India in October 2020.

In order to ensure the effectiveness of COVID-19 nucleic acid detection in epidemic prevention and control, recently, Guangzhou, Fuzhou, Guiyang, Taiyuan, Zhengzhou Hybribio medical laboratory actively participated in the "The preparation of the first national quality evaluation of nucleic acid testing of novel coronavirus variant" in 2021, and achieved 100% qualified results.

The registered Hybribio Novel coronavirus (2019-nCoV) nucleic acid detection kit (Fluorescence Real Time-PCR) , successfully covered by the fluorescent PCR method, which can effectively detect mutant strains, detect B.1.1.7(Alpha), B.1.351(Beta), P.1(Gamma), Fin-796H, B.1.525(Eta), N.9, B.1.616, B.1.617.1,(Kappa), B.1.617.2(Delta), B.1.526(Iota), B.1.427/B.1.429,C.37(Lambda), etc.

In molecular detection, the internal reference gene is not only a control, but also an important link to ensure the quality of test results. If the novel coronavirus detection product adopts the public version of RNaseP human endogenous internal reference, it does not design primer probes across introns. It monitors dnarna. In case of RNA quality problems, it cannot truly and effectively monitor RNA viruses. One of the features of Hybribio COVID-19 Real-Time PCR Kit is to design primer probes using intron RNA introns and monitor the detection of RNA by introns. The quality control of sampling, preservation, extraction and amplification is more effective. By testing the national sensitivity reference material and meeting the corresponding regulations, S1 ~ S5 can be detected as positive, and the concentration of S5 is 412 copies/ml.

Prior to the Ruili, Yunnan the mass nucleic acid testing, Hybribio COVID-19 nucleic acid detection reagent detected the positive samples of the sister to the national community and the isolation point, and verified by the Yunnan Center for Disease Control and Prevention, the positive detection was completely consistent with the Yunnan provincial disease control experts.

Hybribio group has experienced the test of multiple places and rounds of epidemic prevention and control screening, and has accumulated mature anti epidemic experience from the production of supporting novel coronavirus reagents, consumables and instruments to testing technicians and operation management. Hybribio, under the leadership of local governments and related departments, has always worked with the medical workers to fight the first line of battle in China, providing protection for the lives and health of the whole nation, and fully cooperating with the state in fighting New Coronavirus's prevention and control, and to carry out the “Healthy China Initiative” together.

——We sincerely invite global partners——

Email: isw@hybribio.cn

Tel: 0768-2852923 Ext.8193